Clinical studies with aldoxorubicin demonstrated increased progression-free survival and tumor response with low cardiotoxicity
PR Newswire
LOS ANGELES, June 21, 2018
PR Newswire
LOS ANGELES, June 21, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey